Amylyx Pharmaceuticals Inc. Skyrocketed
Fri, Jun 03, 2022 at 05:30 PM
Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ) shot up at $12.35, a gain of 26.4%. On Thu, Jun 02, 2022, AMLX:NASDAQ hit a New 2-Week High of $9.77. The stock appeared on our News Catalysts scanner on Fri, Jun 03, 2022 at 12:46 PM in the 'IPO' category. From Fri, May 20, 2022, the stock recorded 62.50% Up Days and 44.44% Green Days
About Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ)
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Top 10 Gainers:
- Turning Point Therapeutics, Inc. (TPTX:NASDAQ), 118.35%
- Energy Focus, Inc. (EFOI:NASDAQ), 48.65%
- Galecto Inc. (GLTO:NASDAQ), 35.17%
- Yumanity Therapeutics Inc. (YMTX:NASDAQ), 33.96%
- Houston American Energy Corp. (HUSA:NYSEMKT), 27.54%
- Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ), 26.41%
- Forian Inc. (FORA:NASDAQ), 24.23%
- Integrated Media Technology Limited (IMTE:NASDAQ), 22.88%
- Eros STX Global Corporation A (ESGC:NYSE), 22.18%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 21.21%